Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Felipe Fregni, M.D.


This page shows the publications co-authored by Felipe Fregni and Jeffrey Schneider.
Connection Strength

  1. A review of burn symptoms and potential novel neural targets for non-invasive brain stimulation for treatment of burn sequelae. Burns. 2021 05; 47(3):525-537.
    View in: PubMed
    Score: 0.226
  2. Longitudinal Clinical Trial Recruitment and Retention Challenges in the Burn Population: Lessons Learned From a Trial Examining a Novel Intervention for Chronic Neuropathic Symptoms. J Burn Care Res. 2019 10 16; 40(6):792-795.
    View in: PubMed
    Score: 0.216
  3. Distinct behavioral response of primary motor cortex stimulation in itch and pain after burn injury. Neurosci Lett. 2019 01 18; 690:89-94.
    View in: PubMed
    Score: 0.201
  4. A Preliminary Study on qEEG in Burn Patients With Chronic Pruritus. Ann Rehabil Med. 2017 Aug; 41(4):693-700.
    View in: PubMed
    Score: 0.186
  5. Psychological sequelae of the station nightclub fire: Comparing survivors with and without physical injuries using a mixed-methods analysis. PLoS One. 2014; 9(12):e115013.
    View in: PubMed
    Score: 0.155
  6. Chronic pain following physical and emotional trauma: the station nightclub fire. Front Neurol. 2014; 5:86.
    View in: PubMed
    Score: 0.149
  7. A feasibility study assessing cortical plasticity in chronic neuropathic pain following burn injury. J Burn Care Res. 2013 Jan-Feb; 34(1):e48-52.
    View in: PubMed
    Score: 0.135
  8. The long-term impact of physical and emotional trauma: the station nightclub fire. PLoS One. 2012; 7(10):e47339.
    View in: PubMed
    Score: 0.133
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.